Articles related to CHILD & ADOLESCENT PSYCHIATRY

Triple-release dexmethylphenidate formulation demonstrated dose-dependent ADHD symptom improvements with effect sizes ranging from 0.737 to 1.185 across all tested doses in pediatric patients.

Clinical practice observations of AVN following hip injury where non-adherence to activity restrictions was a contributing factor highlight the intersection of medication effects and behavioral challenges in ADHD patients.

Team-based care with expanded medical assistant roles, early rooming protocols, and child psychiatry consultation services can meaningfully increase clinician time with patients while enhancing provider confidence in BMH management.

Children actively construct their understanding of the world through distinct developmental stages, each characterized by qualitative differences in cognitive processing rather than simply accumulated knowledge.

Analysis of more than 5 million adolescent insurance claims reveals that gender-affirming medication prescriptions remain exceptionally rare, with peak rates reaching only 140.16 per 100,000 at age 17 for AFAB adolescents.

Heavy cannabis users showed reduced activity in key brain regions associated with working memory, with 63% demonstrating measurable changes in cognitive function during specific tasks.